<DOC>
	<DOCNO>NCT02311868</DOCNO>
	<brief_summary>The interest gastrointestinal ( GI ) dysfunction hemodialysis grow last year . accept GI dysfunction dialyze patient may contribute systemic microinflammation promote gut dysbiosis bacterial translocation blood . Another mechanism GI dysfunction contributes systemic symptom related metabolic activity dysbiotic microflora grow gut patient generate toxic compound phenol , indoles , amine . Epidemiological evidence strongly link one compound , p-Cresol , cardiovascular risk mortality hemodialysis patient . In present paper investigator investigate effect probiotic/prebiotic mixture plasma p-cresol concentration GI symptom hemodialysis patient .</brief_summary>
	<brief_title>Effect Short-term Synbiotic Treatment Plasma P-cresol Levels Hemodialysis Patients</brief_title>
	<detailed_description>In patient end stage renal disease , alteration gut microbioma posit responsible gastrointestinal symptom generation p-cresol , uremic toxin , associate cardiovascular mortality . This double blind randomize placebo control pilot study evaluate whether Probinul-neutro® , synbiotic preparation normalize intestinal microflora , may lower plasma p-cresol concentration reduce gastrointestinal symptom hemodialysis patient . Thirty patient hemodialysis randomize receive either Probinul neutro® placebo four week . Total plasma p-cresol concentration assess baseline , 15 30 day treatment start . At study time , ease frequency defecation , upper low abdominal pain , stool shape , borborygmi flatus quantify subjective assessment questionnaire .</detailed_description>
	<criteria>hemodialysis age &gt; 18 year severe infection diabetes malignancy history food intolerance autoimmune disorder severe malnutrition clinical condition require artificial feed kidney transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>